Allen, Mariet
Carrasquillo, Minerva M.
Funk, Cory
Heavner, Benjamin D.
Zou, Fanggeng
Younkin, Curtis S.
Burgess, Jeremy D.
Chai, High-Seng
Crook, Julia
Eddy, James A.
Li, Hongdong
Logsdon, Ben http://orcid.org/0000-0002-0572-2569
Peters, Mette A.
Dang, Kristen K.
Wang, Xue
Serie, Daniel
Wang, Chen http://orcid.org/0000-0003-2638-3081
Nguyen, Thuy
Lincoln, Sarah
Malphrus, Kimberly
Bisceglio, Gina
Li, Ma
Golde, Todd E.
Mangravite, Lara M. http://orcid.org/0000-0001-7841-3612
Asmann, Yan
Price, Nathan D.
Petersen, Ronald C.
Graff-Radford, Neill R.
Dickson, Dennis W.
Younkin, Steven G.
Ertekin-Taner, Nilüfer
Article History
Received: 8 April 2016
Accepted: 31 August 2016
First Online: 11 October 2016
Competing interests
: Below are the disclosures for R.C.P.: Pfizer, Inc., and Janssen Alzheimer Immunotherapy: Chair, Data Monitoring Committee. Hoffman-La Roche, Inc.: Consultant. Merck, Inc.: Consultant. Genentech, Inc.: Consultant. Biogen, Inc.: Consultant. Eli Lilly & Co.: Consultant. N.R.G.-R. has multicenter treatment study grants from Lilly and TauRx and consulted for Cytox. N.E.-T. has consulted for Cytox. The remaining authors declare no competing financial interests.